Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen

Autor: Greene, Warner, Usmani, SM, Zirafi, O, Müller, JA, Sandi-Monroy, NL, Yadav, JK, Meier, C, Weil, T, Roan, NR, Greene, WC, Walther, P

Publikováno v: Greene, Warner; Usmani, SM; Zirafi, O; Müller, JA; Sandi-Monroy, NL; Yadav, JK; et al.(2014). Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/8kk4s93m

Naturally occurring fragments of the abundant semen proteins prostatic acid phosphatase (PAP) and semenogelins form amyloid fibrils in vitro. These fibrils boost HIV infection and may play a key role in the spread of the AIDS pandemic. However, the p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::d908a513118173451a2df4464c55d1b1
http://www.escholarship.org/uc/item/8kk4s93m

Proposal for a qualification system for New Approach Methodologies (NAMs) in the food and feed sector: example of implementation for nanomaterial risk assessment.

Autor: Haase, Andrea¹ (AUTHOR) MESE@efsa.europa.eu, Barroso, João² (AUTHOR), Bogni, Alessia² (AUTHOR), Bremer‐Hoffmann, Susanne² (AUTHOR), Fessard, Valerie³ (AUTHOR), Gutleb, Arno C.⁴ (AUTHOR), Mast, Jan⁵ (AUTHOR), McVey, Emily⁶ (AUTHOR), Mertens, Birgit⁵ (AUTHOR), Oomen, Agnes G.^6,7 (AUTHOR), Ritz, Vera¹ (AUTHOR), Serchi, Tommaso⁴ (AUTHOR), Siewert, Katherina¹ (AUTHOR), Stanco, Deborah² (AUTHOR), Usmani, Shirin M.¹ (AUTHOR), Verleysen, Eveline⁵ (AUTHOR), Vincentini, Olimpia⁸ (AUTHOR), van der Zande, Meike⁹ (AUTHOR), Cubadda, Francesco⁸ (AUTHOR)

Publikováno v: EFSA Supporting Publications. Sep2024, Vol. 21 Issue 9, p1-96. 96p.

Targeting the CBM complex causes T reg cells to prime tumours for immune checkpoint therapy.

Autor: Di Pilato M; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA. mdipilato@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. mdipilato@mgh.harvard.edu., Kim EY; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Cadilha BL; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA., Prüßmann JN; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Nasrallah MN; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Seruggia D; Harvard Medical School, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Usmani SM; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Misale S; Harvard Medical School, Boston, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Zappulli V; Department of Comparative Biomedicine and Food Science, University of Padua, Padova, Italy., Carrizosa E; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mani V; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ligorio M; Harvard Medical School, Boston, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Warner RD; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA., Medoff BD; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Marangoni F; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Villani AC; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mempel TR; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA. tmempel@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. tmempel@mgh.harvard.edu.

Publikováno v: Nature [Nature] 2019 Jun; Vol. 570 (7759), pp. 112-116. Date of Electronic Publication: 2019 May 15.

Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone loss.

Autor: Raynaud-Messina B; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Paul Sabatier, 31400 Toulouse Cedex 4, France; raynaud@ipbs.fr maridono@ipbs.fr verollet@ipbs.fr.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 31000 Toulouse, France.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 1425 Buenos Aires, Argentina., Bracq L; INSERM U1016, Institut Cochin, 75014 Paris, France.; CNRS UMR8104, Université Paris Descartes, 75006 Paris, France.; Institut Pasteur Shanghai, Chinese Academy of Sciences, 200000 Shanghai, China., Dupont M; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Paul Sabatier, 31400 Toulouse Cedex 4, France.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 31000 Toulouse, France.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 1425 Buenos Aires, Argentina.; Institute of Experimental Medicine-Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina, National Academy of Medicine, 1425 Buenos Aires, Argentina., Souriant S; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Paul Sabatier, 31400 Toulouse Cedex 4, France.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 31000 Toulouse, France.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 1425 Buenos Aires, Argentina., Usmani SM; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, MA 02129.; Harvard Medical School, Boston, MA 02115., Proag A; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Paul Sabatier, 31400 Toulouse Cedex 4, France., Pingris K; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Paul Sabatier, 31400 Toulouse Cedex 4, France.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 31000 Toulouse, France.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 1425 Buenos Aires, Argentina., Soldan V; Multiscale Electron Imaging Platform, 31062 Toulouse, France., Thibault C; Laboratory for Analysis and Architecture of Systems, CNRS, 31400 Toulouse, France.; Institut National des Sciences Appliquées de Toulouse, Université de Toulouse, 31400 Toulouse, France., Capilla F; INSERM, Université Paul Sabatier, École Nationale Vétérinaire de Toulouse, Centre Régional d'Exploration Fonctionnelle et de Ressources Expérimentales, Service d'Histopathologie, 31000 Toulouse Cedex 3, France., Al Saati T; INSERM, Université Paul Sabatier, École Nationale Vétérinaire de Toulouse, Centre Régional d'Exploration Fonctionnelle et de Ressources Expérimentales, Service d'Histopathologie, 31000 Toulouse Cedex 3, France., Gennero I; Centre de Physiopathologie de Toulouse-Purpan, INSERM-CNRS UMR 1043, Université Paul Sabatier, 31062 Toulouse, France.; Institut Fédératif de Biologie, Centre Hospitalier Universitaire Toulouse, 31059 Toulouse, France., Jurdic P; Institut de Génomique Fonctionnelle de Lyon, CNRS UMR3444, Université de Lyon, Ecole Normale Supérieure de Lyon, 69007 Lyon, France., Jolicoeur P; Division of Experimental Medicine, McGill University, Montreal, QC H3G 1A4, Canada.; Department of Microbiology and Immunology, University of Montreal, Montreal, QC H3T IJ4, Canada.; Laboratory of Molecular Biology, Clinical Research Institute of Montreal, Montreal, QC H2W 1R7, Canada., Davignon JL; INSERM, Université Paul Sabatier, École Nationale Vétérinaire de Toulouse, Centre Régional d'Exploration Fonctionnelle et de Ressources Expérimentales, Service d'Histopathologie, 31000 Toulouse Cedex 3, France.; Centre de Physiopathologie de Toulouse-Purpan, INSERM-CNRS UMR 1043, Université Paul Sabatier, 31062 Toulouse, France., Mempel TR; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, MA 02129.; Harvard Medical School, Boston, MA 02115., Benichou S; INSERM U1016, Institut Cochin, 75014 Paris, France.; CNRS UMR8104, Université Paris Descartes, 75006 Paris, France.; Institut Pasteur Shanghai, Chinese Academy of Sciences, 200000 Shanghai, China., Maridonneau-Parini I; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Paul Sabatier, 31400 Toulouse Cedex 4, France; raynaud@ipbs.fr maridono@ipbs.fr verollet@ipbs.fr.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 31000 Toulouse, France.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 1425 Buenos Aires, Argentina., Vérollet C; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Paul Sabatier, 31400 Toulouse Cedex 4, France; raynaud@ipbs.fr maridono@ipbs.fr verollet@ipbs.fr.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 31000 Toulouse, France.; International Associated Laboratory, CNRS 'Immuno-Metabolism-Macrophages-Tuberculosis/HIV' (1167), 1425 Buenos Aires, Argentina.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Mar 13; Vol. 115 (11), pp. E2556-E2565. Date of Electronic Publication: 2018 Feb 20.

Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review.

Autor: Li, Yu¹ (AUTHOR), Zhang, Cangang² (AUTHOR), Jiang, Aimin³ (AUTHOR), Lin, Anqi¹ (AUTHOR), Liu, Zaoqu^4,5 (AUTHOR), Cheng, Xiangshu⁶ (AUTHOR), Wang, Wanting⁷ (AUTHOR), Cheng, Quan⁸ (AUTHOR) chengquan@csu.edu.cn, Zhang, Jian¹ (AUTHOR) zhangjian@i.smu.edu.cn, Wei, Ting¹ (AUTHOR) weitingyouyou@qq.com, Luo, Peng¹ (AUTHOR) luopeng@smu.edu.cn

Publikováno v: Journal of Translational Medicine. 3/20/2024, Vol. 22 Issue 1, p1-21. 21p.